GSK reports 30% jump in first-quarter profits as demand for its vaccines booms
Revenue edged 6% higher in the quarter to £7.66bn, with almost all of that growth coming from the vaccines business
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
746 stories · page 21 of 38
Archive
Will Next spring a surprise in Wednesday’s first-quarter trading update?
There’s a lot for investors to get their teeth into on Wednesday, with Sainsbury’s, GSK and Persimmon among the slew of companies reporting alongside Next
Why the FTSE 100 is not the UK’s economic bellwether
While the index does contain the heavyweights of the London market, they're not the most reliable indicator of how the UK's markets are actually performing
Investments and investor services
Andalas subsides after finance director resigns
A look at the day's major movers, including Gordon Dadds, Motif Bio, Proton Power, Regal Petroleum, Saga and Xeros Technology
Archive
Proactive news snapshot: ReNeuron Group PLC, Tissue Regenix Group PLC, ANGLE PLC, Motif Bio PLC …
A glance at some of the day's highlights from the Proactive Investors newswire
Hardware & electrical equipment
Frontier IP investee company achieves major milestone in GSK collaboration
Exscientia has delivered a lead molecule using artificial intelligence
Investments and investor services
FTSE 100 closes in positive territory, boosted by better-than-expected US March jobs figures as Brexit uncertainty continues
Mid-cap cousin FTSE 250 was also lower, shedding around 56 points at 19,507
Vectura racks up huge loss following failure of severe asthma inhaler in late-stage study
The drugmaker decided to write down the value of its VR745 asthma treatment to zero following its late-stage trial failure back in November
Frontier IP upgrades full year forecasts as portfolio firm Exscientia inks deal with biotech giant Celgene
The collaboration included an initial upfront payment of US$25mln for Exscientia in addition to “substantial milestones” and tiered royalties on net sales of any product developed
GlaxoSmithKline unit ViiV moves a decisive step closer to producing monthly HIV jab
The update comes in the week that it emerged a third person had possibly been cured of a disease that was during the 1980s considered a death sentence
Builders and building materials
Crest Nicolson appoints Sainsbury executive as new group finance director
Duncan Cooper, the director of group finance at Sainsbury’s, will replace Robert Allen, who left the company in October 2018 following a profit warning
UBS strips GSK of ‘buy’ recommendation on near-term fears for its ViiV HIV division
ViiV has been GSK’s star performer in recent years, but UBS is worried that the launch of a rival HIV drug will see patients switch to other treatments
FTSE 100 closes in the red as US stocks take a hit; Centrica tanks
Risers on the Footsie were outnumbered 3 to 1 by fallers
Archive
Barclays to round off trio of UK banking results on Thursday
Barclays will be a highlight in Thursday's schedule.
Be Heard makes strong start to 2019 after year of transformation
"The group has had a good start to the year," chairman David Morrison said.
Archive
Banking results to flow faster, with Barclays, Lloyds, and HSBC all set to report 2018 numbers
Aside from the banking results, the week ahead will bring updates from other blue-chips firms such as BAE Systems, Anglo American, Pearson, and Reckitt Benckiser
GSK to take £790mln hit from launch of Advair copycat
Dutch pharma giant Mylan won approval from the US Food and Drug Administration last week to launch its version of Advair, which generated sales of almost £2.5bn last year
Investments and investor services
FTSE 100 closes a tad lower ahead of BoE Super Thursday
The UK index of leading shares closed down around four points at 7,173
Archive
Big Pharma is big news for Wednesday as GSK reports results for 2018
The launch of a generic rival to its Advair inhaler has many expecting a downgrade to Glaxo's outlook
Archive
Bank of England's 'Super Thursday' and slew of corporate earnings eyed as Chinese New Year begins
The week ahead includes updates from Thomas Cook, Superdry, Ryanair and Tate & Lyle, among others.